BMS Named 2024 Best Place to Work for Disability Inclusion in US, UK and Brazil by the Disability Equality Index®
PRINCETON, N.J., July 17, 2024 /3BL/ - Bristol Myers Squibb (NYSE: BMY) has earned a top score of 100 on the 2024 Disability Equality Index®, naming BMS a Best Place to Work for Disability Inclusion in the U.S., U.K. and Brazil. BMS has earned this score for the sixth consecutive year in the U.S. and for the first time in the U.K. and Brazil.
The Disability Equality Index® is the world’s most comprehensive benchmarking tool used to measure disability inclusion for Fortune 1000 companies across key performance indicators for culture and leadership, accessibility employment, community engagement, supplier diversity and procurement.
“This recognition quantifies our hard work and continuous advancement toward disability inclusion,” said Peter Paine, senior vice president, chief of staff to the CEO, Bristol Myers Squibb. “We are committed to fostering a high-performing, inclusive global workforce and an environment where employees can be at their best to deliver the best for patients.”
BMS executes on several strategic initiatives across the company to implement disability inclusion. These initiatives include accessibility infrastructure improvements, people business and resource groups, enhanced training programs and program tools, support and advocacy for employees, universal design features and IT accessibility and inclusive hiring practices.
Learn more about BMS’ commitment to fostering a high-performing and inclusive workforce in its 2023 ESG Report.
About the Disability Equality Index®
The Disability Equality Index has become the leading independent, third-party resource for the annual benchmarking of corporate disability inclusion policies and programs, and is now trusted by more than 70% of the United States Fortune 100 and nearly half of the Fortune 500. Such companies must increasingly consider how emerging global reporting directives and stakeholder expectations surrounding social and corporate governance factors impact their operational, cultural, reputational and financial performance.
The Disability Equality Index is an objective, reflective, forward-thinking, and confidential disability rating tool designed to assist business in advancing inclusion practices. It is a comprehensive benchmark that helps companies build a roadmap of measurable, tangible actions across five scored categories: Culture & Leadership, Enterprise-Wide Access, Employment Practices, Community Engagement, and Supplier Diversity. Participating companies receive a score, on a scale of zero (0) to 100, with those scoring 80 or higher earning the distinction of “Best Places to Work for Disability Inclusion” for the benchmark year.
Findings from a two-year Global Disability Equality Index pilot informed the launch of a scored benchmark that opened in 2024 to seven new countries in addition to the United States. These include: Brazil, Canada, Germany, India, Japan, the Philippines, and the United Kingdom. Now in its 10th year, the Disability Equality Index has grown nearly 7x since 2015, expanding from 80 companies in its first year to 542 in 2024. Collectively, the 2024 edition received 753 submissions spanning the eight benchmarked countries.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X (formerly Twitter), YouTube, Facebook and Instagram.
